<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9660">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02981186</url>
  </required_header>
  <id_info>
    <org_study_id>PHY1603</org_study_id>
    <nct_id>NCT02981186</nct_id>
  </id_info>
  <brief_title>Comparison of Visual Outcomes After Implantation of the POD AY GF F (PhysIOL) and the POD AY 26P F (PhysIOL)</brief_title>
  <official_title>Comparison of Visual Outcomes After Implantation of the POD AY GF F (PhysIOL) and the POD AY 26P F (PhysIOL)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Physiol</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Physiol</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective randomised controlled study. The patients get monolateral IOL
      implantation of POD F GF and POD F in the contralateral eye. Both IOLs are trifocal IOLs
      consisting of the same optical design. The difference between the IOLs is the material
      (hydrophilic and hydrophobic).

      To decide which eye receives POD F and which eye receives POD F GF, a randomization table
      will be provided to the principle investigator.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The examinations consist of visual acuity data, contrast sensitivity exams and slitlamp
      examinations.

      Follow up will be up to 6 months postoperative.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity at far, near and intermediate distance</measure>
    <time_frame>6 months postoperative</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Cataract</condition>
  <condition>Lens Opacity</condition>
  <arm_group>
    <arm_group_label>IOL Implantation experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implantation of POD F GF in one of the eyes of the study subject</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IOL Implantation Comparator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implantation of POD F in the contralateral eye of the study subject</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IOL implantation experimental</intervention_name>
    <description>Implantation of trifocal IOL POD F GF consisting of hydrophobic material</description>
    <arm_group_label>IOL Implantation experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IOL implantation comparator</intervention_name>
    <description>Implantation of trifocal IOL POD F consisting of hydrophilic material</description>
    <arm_group_label>IOL Implantation Comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cataractous Eyes with no comorbidity

          -  Patient older than 50 years old

          -  Regular corneal astigmatism &lt;0.75 dioptres by an automatic keratometer (regularity
             determined by the topography of the keratometry) or &lt;1.0 dioptres if the steep axis
             of cylinder is between 90° and 120°

          -  Spontaneously emitting the desire for spectacle independence after surgery and with
             realistic expectation.

          -  Availability, willingness and sufficient cognitive awareness to comply with
             examination procedures

          -  Signed informed consent

        Exclusion Criteria:

          -  Unrealistic expectation

          -  Irregular astigmatism

          -  Difficulty for cooperation (distance from their home, general health condition)

          -  Acute or chronic disease or illness that would increase risk or confound study
             results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…)

          -  Any ocular comorbidity

          -  History of ocular trauma or prior ocular surgery including refractive procedures

          -  Capsule or zonular abnormalities that may affect postoperative centration or tilt of
             the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome)

          -  Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils
             that do not dilate under mesopic/scotopic conditions)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zoltan Nagy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Semmelweis University - Department of Ophthalmology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jochen Kandulla, PhD</last_name>
    <phone>+49 157 86275281</phone>
    <email>j.kandulla@physiol.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Semmelweis University - Department of Ophthalmology</name>
      <address>
        <city>Budapest</city>
        <zip>1085</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zoltan Nagy, MD</last_name>
      <phone>+36-1-303-9435</phone>
      <email>zoltan.nagy100@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Huba Kiss, MD</last_name>
      <email>kisshuba@googlemail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Zoltan Nagy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 30, 2016</lastchanged_date>
  <firstreceived_date>November 29, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intraocular Lens</keyword>
  <keyword>trifocal</keyword>
  <keyword>cataract</keyword>
  <keyword>PhysIOL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
